- Home
- NHTC vs ANL Comparison
NHTC vs ANL Comparison
Compare NHTC & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- ANL
- Stock Information
- Founded
- NHTC 1988
- ANL 2004
- Country
- NHTC United States
- ANL Cayman Islands
- Employees
- NHTC N/A
- ANL N/A
- Industry
- NHTC Diversified Commercial Services
- ANL
- Sector
- NHTC Miscellaneous
- ANL
- Exchange
- NHTC Nasdaq
- ANL Nasdaq
- Market Cap
- NHTC 53.3M
- ANL 56.0M
- IPO Year
- NHTC 1995
- ANL 2023
- Fundamental
- Price
- NHTC $4.72
- ANL $1.47
- Analyst Decision
- NHTC
- ANL Hold
- Analyst Count
- NHTC 0
- ANL 1
- Target Price
- NHTC N/A
- ANL N/A
- AVG Volume (30 Days)
- NHTC 13.9K
- ANL 6.9K
- Earning Date
- NHTC 07-30-2025
- ANL 08-12-2025
- Dividend Yield
- NHTC 17.20%
- ANL N/A
- EPS Growth
- NHTC N/A
- ANL N/A
- EPS
- NHTC 0.03
- ANL N/A
- Revenue
- NHTC $42,087,000.00
- ANL N/A
- Revenue This Year
- NHTC N/A
- ANL N/A
- Revenue Next Year
- NHTC N/A
- ANL N/A
- P/E Ratio
- NHTC $154.95
- ANL N/A
- Revenue Growth
- NHTC N/A
- ANL N/A
- 52 Week Low
- NHTC $4.02
- ANL $1.10
- 52 Week High
- NHTC $7.35
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- NHTC 59.45
- ANL 46.56
- Support Level
- NHTC $4.59
- ANL $1.48
- Resistance Level
- NHTC $4.73
- ANL $1.55
- Average True Range (ATR)
- NHTC 0.12
- ANL 0.04
- MACD
- NHTC 0.02
- ANL 0.00
- Stochastic Oscillator
- NHTC 91.20
- ANL 37.50
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.